Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical

Quantum Genomics SA

20/07/2023 17:16

July 20 (Reuters) - Quantum Genomics SA  ALQGC.PA :
    * QUANTUM GENOMICS ENTERS INTO EXCLUSIVE NEGOTIATIONS WITH
VISTACARE MEDICAL
    * A BUSINESS MODEL OFFERING STRONG RECURRING REVENUE AND
VISIBILITY
    * MERGER COMPLETION IS EXPECTED IN Q4 OF 2023
    * FINANCIAL VISIBILITY EXTENDED UNTIL Q2 OF 2024, WITH A
CONSOLIDATED CASH POSITION ESTIMATED AT 4.3 MILLION EUROS AS OF
MERGER'S CLOSING DATE
    * VISTACARE MEDICAL'S TECHNOLOGICAL BREAKTHROUGH HAS ALLOWED
IT TO
RAISE 7.2 MILLION EUROS SINCE ITS INCEPTION, INCLUDING 4 MILLION
EUROS IN CAPITAL FROM TWO INVESTMENT FUNDS

Source text for Eikon:  ID:nACT81094 
Further company coverage:  ALQGC.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))